Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Françoise Galateau-Salle |
| Publication date | March 31, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |